Oligonucleotide aptamers: new tools for targeted cancer therapy

H Sun, X Zhu, PY Lu, RR Rosato, W Tan… - Molecular Therapy-Nucleic …, 2014 - cell.com
Aptamers are a class of small nucleic acid ligands that are composed of RNA or single-
stranded DNA oligonucleotides and have high specificity and affinity for their targets. Similar …

Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer

M Razlansari, S Jafarinejad, A Rahdar… - Molecular and Cellular …, 2023 - Springer
Today, RNA aptamers are being considered promising theranostic tools against a wide
variety of disorders. RNA aptamers can fold into complex shapes and bind to diverse …

Aptamer-based microfluidics for isolation, release and analysis of circulating tumor cells

L Wu, L Zhu, M Huang, J Song, H Zhang, Y Song… - TrAC Trends in …, 2019 - Elsevier
The analysis of circulating tumor cells (CTCs) holds great significance for cancer diagnosis,
prognosis, and personalized therapy. However, the rarity, vulnerability and heterogeneity of …

Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies

A Alexaki, GK Hettiarachchi, JC Athey, UK Katneni… - Scientific reports, 2019 - nature.com
Synonymous codons occur with different frequencies in different organisms, a phenomenon
termed codon usage bias. Codon optimization, a common term for a variety of approaches …

The clinical potential of oligonucleotide therapeutics against pancreatic cancer

K Takakura, A Kawamura, Y Torisu, S Koido… - International journal of …, 2019 - mdpi.com
Although many diagnostic and therapeutic modalities for pancreatic cancer have been
proposed, an urgent need for improved therapeutic strategies remains. Oligonucleotide …

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma

Q Li, SH Maier, P Li, J Peterhansl, C Belka, J Mayerle… - Radiation …, 2020 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is an extremely challenging disease with a high
mortality rate and a short overall survival time. The poor prognosis can be explained by …

Nucleic acid therapeutics: a focus on the development of aptamers

S Jain, J Kaur, S Prasad, I Roy - Expert Opinion on Drug Discovery, 2021 - Taylor & Francis
Introduction Aptamers provide exciting opportunities for the development of specific and
targeted therapeutic approaches. Areas covered In this review, the authors discuss different …

Aptamers: Promising tools for the detection of circulating tumor cells

EM Hassan, WG Willmore, MC DeRosa - Nucleic acid therapeutics, 2016 - liebertpub.com
Circulating tumor cells (CTCs) are cells that shed from a primary tumor and freely circulate in
the blood, retaining the ability to initiate metastasis and form a secondary tumor in distant …

In vitro selections of mammaglobin A and mammaglobin B aptamers for the recognition of circulating breast tumor cells

EM Hassan, WG Willmore, BC McKay, MC DeRosa - Scientific reports, 2017 - nature.com
Mammaglobin B (MGB2) and mammaglobin A (MGB1) are proteins expressed in metastatic
breast cancers. The early detection of circulating tumor cells (CTCs) in breast cancer …

Trends in the design and development of specific aptamers against peptides and proteins

M Tabarzad, M Jafari - The Protein Journal, 2016 - Springer
Aptamers are single stranded oligonucleotides, comparable to monoclonal antibodies
(mAbs) in selectivity and affinity and have significant strategic properties in design …